Maryland Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $462K | Sell |
6,495
-500
| -7% | -$36.3K | 0.04% | 151 |
|
|
2022
Q2 | $539K | Hold |
6,995
| – | – | 0.04% | 145 |
|
|
2022
Q1 | $511K | Sell |
6,995
-288
| -4% | -$19.3K | 0.03% | 161 |
|
|
2021
Q4 | $454K | Sell |
7,283
-528
| -7% | -$31K | 0.02% | 176 |
|
|
2021
Q3 | $462K | Buy |
7,811
+472
| +6% | +$31.1K | 0.03% | 169 |
|
|
2021
Q2 | $490K | Sell |
7,339
-1,247
| -15% | -$81.3K | 0.03% | 167 |
|
|
2021
Q1 | $542K | Sell |
8,586
-4,590
| -35% | -$286K | 0.04% | 149 |
|
|
2020
Q4 | $817K | Buy |
13,176
+13
| +0.1% | +$799 | 0.06% | 115 |
|
|
2020
Q3 | $794K | Sell |
13,163
-2,504
| -16% | -$151K | 0.07% | 107 |
|
|
2020
Q2 | $921K | Sell |
15,667
-267
| -2% | -$16K | 0.09% | 95 |
|
|
2020
Q1 | $888K | Sell |
15,934
-1,390
| -8% | -$85K | 0.11% | 94 |
|
|
2019
Q4 | $1.11M | Buy |
17,324
+480
| +3% | +$27.5K | 0.12% | 92 |
|
|
2019
Q3 | $854K | Sell |
16,844
-885
| -5% | -$41.6K | 0.1% | 105 |
|
|
2019
Q2 | $804K | Sell |
17,729
-1,510
| -8% | -$70.3K | 0.1% | 103 |
|
|
2019
Q1 | $918K | Sell |
19,239
-295
| -2% | -$14.7K | 0.11% | 95 |
|
|
2018
Q4 | $1.01M | Buy |
19,534
+230
| +1% | +$12.4K | 0.15% | 85 |
|
|
2018
Q3 | $1.2M | Sell |
19,304
-960
| -5% | -$57K | 0.16% | 82 |
|
|
2018
Q2 | $1.12M | Sell |
20,264
-1,304
| -6% | -$70.4K | 0.16% | 83 |
|
|
2018
Q1 | $1.36M | Buy |
21,568
+3,426
| +19% | +$220K | 0.2% | 76 |
|
|
2017
Q4 | $1.11M | Buy |
18,142
+85
| +0.5% | +$5.32K | 0.16% | 78 |
|
|
2017
Q3 | $1.15M | Sell |
18,057
-490
| -3% | -$28.6K | 0.18% | 78 |
|
|
2017
Q2 | $1.03M | Sell |
18,547
-840
| -4% | -$45.7K | 0.15% | 86 |
|
|
2017
Q1 | $1.05M | Buy |
19,387
+277
| +1% | +$15.2K | 0.16% | 84 |
|
|
2016
Q4 | $1.12M | Sell |
19,110
-1,220
| -6% | -$66.7K | 0.17% | 81 |
|
|
2016
Q3 | $1.1M | Buy |
20,330
+835
| +4% | +$53.6K | 0.16% | 79 |
|
|
2016
Q2 | $1.43M | Sell |
19,495
-6,006
| -24% | -$424K | 0.23% | 68 |
|
|
2016
Q1 | $1.63M | Sell |
25,501
-1,420
| -5% | -$89.5K | 0.23% | 63 |
|
|
2015
Q4 | $1.85M | Sell |
26,921
-600
| -2% | -$39.6K | 0.27% | 59 |
|
|
2015
Q3 | $1.63M | Sell |
27,521
-2,733
| -9% | -$173K | 0.28% | 62 |
|
|
2015
Q2 | $2.01M | Sell |
30,254
-912
| -3% | -$60.1K | 0.31% | 54 |
|
|
2015
Q1 | $2.01M | Buy |
31,166
+578
| +2% | +$36.2K | 0.31% | 55 |
|
|
2014
Q4 | $1.81M | Buy |
30,588
+660
| +2% | +$37.2K | 0.3% | 60 |
|
|
2014
Q3 | $1.53M | Buy |
29,928
+300
| +1% | +$15K | 0.26% | 66 |
|
|
2014
Q2 | $1.44M | Sell |
29,628
-285
| -1% | -$14K | 0.25% | 67 |
|
|
2014
Q1 | $1.55M | Buy |
29,913
+414
| +1% | +$22K | 0.29% | 65 |
|
|
2013
Q4 | $1.57M | Buy |
29,499
+1,370
| +5% | +$69.8K | 0.25% | 69 |
|
|
2013
Q3 | $1.3M | Buy |
28,129
+1,966
| +8% | +$86.3K | 0.21% | 75 |
|
|
2013
Q2 | $1.17M | Buy |
+26,163
| New | +$1.14M | 0.2% | 83 |
|
Other funds holding BMY
Maryland Capital Management's BMY Position: Q3 2022 in Review
Maryland Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q3 2022, selling an estimated $36.3K and leaving 6,495 shares worth $462K. The position accounts for 0.04% of the portfolio, ranked #151.
Maryland Capital Management first reported a position in BMY in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.01M in Q2 2015. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Maryland Capital Management held 6,495 shares of Bristol-Myers Squibb worth $462K as of Q3 2022.
- Maryland Capital Management sold 500 Bristol-Myers Squibb shares in Q3 2022, an estimated $36.3K.
- Bristol-Myers Squibb made up 0.04% of Maryland Capital Management's portfolio in Q3 2022, its #151 holding.
- Maryland Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 38 quarters since.
- Maryland Capital Management's Bristol-Myers Squibb position peaked at $2.01M in Q2 2015.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.